Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 8

  1. Cat.No. Product Name Information/Activity
  2. BCC6862 2-Iminopiperidine hydrochloride 16011-96-4 2-Iminopiperidine hydrochloride chemical structure
  3. BCC6837 S-Isopropylisothiourea hydrobromide 4269-97-0 S-Isopropylisothiourea hydrobromide chemical structure
  4. BCC6791 (S)-Methylisothiourea sulfate 867-44-7 (S)-Methylisothiourea sulfate chemical structure
  5. BCC5706 L-NIL hydrochloride 150403-89-7 L-NIL hydrochloride chemical structure
  6. BCC6689 L-NIO dihydrochloride L-NIO dihydrochloride is a potent, non-selective and NADPH-dependent nitric oxide synthase (NOS) inhibitor, with Kis of 1.7, 3.9, 3.9 μM for neuronal (nNOS), endothelial (eNOS), and inducible (iNOS), respectively. L-NIO dihydrochloride induces a consistentfocal ischemic infarctin rats. L-NIO dihydrochloride chemical structure
  7. BCC7057 1400W dihydrochloride 1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM. 1400W dihydrochloride chemical structure
  8. BCC2306 Anagrelide HCl Anagrelide hydrochloride (BL4162A) is a drug used for the treatment of essential thrombocytosis. Anagrelide HCl chemical structure
  9. BCC7940 BC 11-38 686770-80-9 BC 11-38 chemical structure
  10. BCN5807 Caffeine 58-08-2 Caffeine chemical structure
  11. BCC6173 Carbazeran citrate 153473-94-0 Carbazeran citrate chemical structure

Items 71 to 80 of 709 total